Relationship between rifampicin-dependent antibody scores, serum rifampicin concentrations and symptoms in patients with adverse reactions to intermittent rifampicin treatment.
D000328:Adult; D000906:Antibodies / Q000032:analysis*; D000917:Antibody Formation; D004342:Drug Hypersensitivity / Q000276:immunology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000906:Antibodies; D012293:Rifampin